
ReNewVax Offering | |
Convertible Redeemable Preference Shares Recommendation Reporting Currency Use of funds |
BUY Pound Sterling Growth |
Sector | Biotech – vaccines |
Key Market Data | |
Market | Private Offering |
Price per Share | €1 |
Number of shares for sale | 3,000,000 |
Total | €3,000,000.00 |
Company Value | €29,000,000 |
Interest Term |
15% Compounded 5 years |
Fiscal Year end | 31st December |
Company Objective | Growth |
Main Shareholders
|
University of Liverpool 37% Management Team 60% |
ReNewVax – 15 % cumulative redeemable preference share offering.